Related Experiment Video
Updated: Jan 10, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Overcoming variable response in renal denervation: Key strategies for reliable clinical implementation
Xianghao Zuo1, Yao Xiao1, Zhipeng Zhang1
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Renal denervation (RDN) shows variable results for resistant hypertension due to patient differences and procedural limits. Optimizing patient selection and ablation techniques can improve RDN treatment response and consistency.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Nephrology
Background:
- Resistant hypertension poses a significant clinical challenge, with limited effective treatment options.
- Renal denervation (RDN) offers a promising therapeutic avenue, but its efficacy is hampered by significant variability and non-response rates.
- The heterogeneity in RDN outcomes is attributed to inter-individual differences in sympathetic nervous system activation and procedural limitations causing incomplete denervation.
Purpose of the Study:
- To review recent advancements in precision patient selection for RDN.
- To explore procedural refinements aimed at improving the consistency and efficacy of RDN.
- To propose a framework for optimizing RDN therapy through integrated patient stratification and ablation techniques.
Main Methods:
- Comprehensive literature review of recent studies on RDN patient selection and procedural techniques.
- Synthesis of data on factors influencing sympathetic nervous system activation in hypertension.
- Analysis of current limitations and innovations in RDN procedures.
Main Results:
- Advances in patient selection strategies are emerging to identify individuals most likely to benefit from RDN.
- Procedural refinements are being developed to enhance the completeness and precision of sympathetic denervation.
- A conceptual framework integrating patient stratification and procedural optimization is proposed to improve therapeutic consistency.
Conclusions:
- Addressing inter-individual variability and procedural limitations is crucial for enhancing RDN efficacy.
- Precision medicine approaches, combining targeted patient selection with refined ablation techniques, are key to unlocking RDN's full potential.
- This work provides insights to support the reliable clinical translation of RDN for resistant hypertension.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Antihypertensive Drugs: Direct Renin Inhibitors